Home
>
National Drug Code (NDC)
>
Glipizide
Glipizide - 0591-0900-01 - (Glipizide)
Drug Information of Glipizide
| Product NDC: | 0591-0900 |
| Proprietary Name: | Glipizide |
| Non Proprietary Name: | Glipizide |
| Active Ingredient(s): | 2.5 mg/1 & nbsp; Glipizide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Glipizide
| Product NDC: | 0591-0900 |
| Labeler Name: | Watson Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076467 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20060401 |
Package Information of Glipizide
| Package NDC: | 0591-0900-01 |
| Package Description: | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-0900-01) |
NDC Information of Glipizide
| NDC Code | 0591-0900-01 |
| Proprietary Name | Glipizide |
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-0900-01) |
| Product NDC | 0591-0900 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Glipizide |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20060401 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Laboratories, Inc. |
| Substance Name | GLIPIZIDE |
| Strength Number | 2.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Sulfonylurea [EPC],Sulfonylurea Compounds [Chemical/Ingredient] |
